PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

15 registration certificates of medicines have been withdrawn from the State Register

The Ministry of Health of the Russian Federation has revoked registration certificates for 15 drugs based on applications from their owners. Of these, 13 belonged to JSC Pharmstandard-Tomskkhimpharm, the rest belonged to JSC Sanofi Russia. Information about this appeared on the GRLS website.

Recalled drugs of JSC Pharmstandard-Tomskkhimpharm: 

“Ethyl alcohol” ((ethanol), LSR-008197/08 dated 10/16/2008);

“Citramon P” (LSR-000021 dated 03/28/2007);

“Furosemide” ((furosemide) LS-000488 dated 11/18/2009);

Prednisone (prednisone) LSR-003276/07 dated 10/17/2007);

“Paracetamol” ((paracetamol) LSR-000062 dated 05/10/2007);

Pantocrine (LSR-003253/07 dated 17.10.2007);

“Nitrosorbide” ((isosorbide dinitrate) LSR-003429/07 dated 10/26/2007);

Peppermint tincture (LSR-003434/07 dated 10/26/2007);

“Levomycetin” ((chloramphenicol) LS-001979 dated 07/9/2010);

“Potassium orotate” ((orotic acid) LSR-003254/07 dated 17.10.2007);

Hawthorn tincture (LS-002044 from 08/25/2009);

“Acetylsalicylic acid” ((acetylsalicylic acid) R N003094/01 dated 12/15/2008);

“Analgin” ((sodium metamizole), P N001244/01 dated 01/23/2008).

Recalled drugs of Sanofi Russia JSC:

“Troxerutin Sanofi” ((troxerutin) N N015161/01 dated 08/13/2008);

“Tritatse” ((ramipril) LSR-008998/09 dated 09.11.2009).

All drugs excluded from the GRLS have registered analogues on the Russian market.

Current news

  • July 7, 2025

    PharmEco to Launch Oncology Drug Production with ₽9.1 Billion Investment

    The PharmEco Group of Companies will build a pharmaceutical manufacturing facility for oncology treatments in…

  • July 7, 2025

    Russian Government Introduces New Procedure for Releasing Medicines into Civil Circulation

    The Russian government has approved updated regulations governing the release of medicines into civil circulation.…

  • July 7, 2025

    National Preference Benefits Will Now Apply to All Russian-Made Medicines, Not Just Those on the Vital Drugs List

    The Russian government has amended its decree on measures for granting national treatment in the…

  • July 7, 2025

    Medicine Sales in Russia Surpass 1 Trillion Rubles Since Beginning of the Year

    From January to April 2025, medicine sales in Russia reached 1.03 trillion rubles. Compared to…

  • July 7, 2025

    Pfizer CEO Proposes a “Pharmaceutical NATO” with Fixed Spending on Medicines

    Pfizer CEO Albert Bourla has called on European countries to increase their spending on medicines.…

LLC “BioJet”. all rights reserved

  • Legal information